238 related articles for article (PubMed ID: 24307696)
21. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
22. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA
Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
25. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.
Shah NM; Zaitseva L; Bowles KM; MacEwan DJ; Rushworth SA
Cell Death Differ; 2015 Apr; 22(4):654-64. PubMed ID: 25323587
[TBL] [Abstract][Full Text] [Related]
26. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
27. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
[TBL] [Abstract][Full Text] [Related]
28. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.
Shibata T; Kokubu A; Saito S; Narisawa-Saito M; Sasaki H; Aoyagi K; Yoshimatsu Y; Tachimori Y; Kushima R; Kiyono T; Yamamoto M
Neoplasia; 2011 Sep; 13(9):864-73. PubMed ID: 21969819
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-induced modification of microRNA expression in esophageal cancer.
Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
31. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
[TBL] [Abstract][Full Text] [Related]
32. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
33. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM
Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006
[TBL] [Abstract][Full Text] [Related]
34. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
Wu K; Yang Y; Zhao J; Zhao S
Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
[TBL] [Abstract][Full Text] [Related]
35. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
[TBL] [Abstract][Full Text] [Related]
36. Down-regulated miR-26a promotes proliferation, migration, and invasion
Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
38. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
Konstantinopoulos PA; Spentzos D; Fountzilas E; Francoeur N; Sanisetty S; Grammatikos AP; Hecht JL; Cannistra SA
Cancer Res; 2011 Aug; 71(15):5081-9. PubMed ID: 21676886
[TBL] [Abstract][Full Text] [Related]
39. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
Osako Y; Seki N; Kita Y; Yonemori K; Koshizuka K; Kurozumi A; Omoto I; Sasaki K; Uchikado Y; Kurahara H; Maemura K; Natsugoe S
Int J Oncol; 2016 Dec; 49(6):2255-2264. PubMed ID: 27779648
[TBL] [Abstract][Full Text] [Related]
40. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
Zhang Z; Xiong R; Li C; Xu M; Guo M
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]